AI agents now operate across enterprise systems, creating new risk via prompt injection, plugins, and persistent memory. Here ...

The Koi deal comes one week after Palo Alto closed its acquisition of CyberArk to bolster its AI security portfolio.

Treatment-Resistant Depression (TRD) stands as one of the most stubborn and costly challenges in modern healthcare. For the millions of patients who have cycled through multiple antidepressants ...

THE next decade will not be defined solely by a single catastrophe but by the slow compounding of environmental stresses that quietly reshape societies and economies. The World Economic Forum’s Global ...

Because permeation and plasma-induced degradation are continuous rather than episodic, their effects accumulate gradually.

Global growth has stabilised and inflation has cooled, but markets are no longer forgiving. As technology rallies narrow and policy paths diverge, AIX Investment Group is repositioning portfolios for ...

There is a specific kind of night only founders understand. You close your laptop after a long day, revenue is not where you ...

AI ambition versus climate responsibility is a false binary. It only appears real when we treat the two as separate ...

CRISPR Therapeutics is commercially validated with CASGEVY but remains financially unproven and operates at a loss. Click to read this CRSP stock update.

Prediction markets such as Polymarket and Kalshi let users win money by correctly guessing the outcome of practically any event.

The people most anxious about money aren't the ones who have the least — they're the ones close enough to comfort to feel ...